High frequency of Plasmodium falciparum chloroquine resistance marker (pfcrt T76 mutation) in Yemen: An urgent need to re-examine malaria drug policy

Parasites and Vectors

Volumn 4, Issue 1, 2011, Pages

  Al Mekhlafi, Abdulsalam M ^a   Mahdy, Mohammed A K ^a,b   Al Mekhlafi, Hesham M ^a,b   Azazy, Ahmed A ^b   Fong, Mun Yik ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b SANA A UNIVERSITY   (Yemen)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; ANTIMALARIAL AGENT; CARRIER PROTEIN; PFCRT PROTEIN, PLASMODIUM FALCIPARUM; PROTOZOAL DNA; PROTOZOAL PROTEIN;

ADULT; ANOPHELES ARABIENSIS; ARTICLE; BED NET; BLOOD SAMPLING; CHOLOROQUINE RESISTANCE; DISEASE CARRIER; FEMALE; GENE MUTATION; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALARIA; MALE; PARASITEMIA; PFCRT 76T GENE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; VIRUS GENE; YEMEN; ADOLESCENT; AGED; CHILD; CROSS-SECTIONAL STUDY; DRUG EFFECT; DRUG RESISTANCE; GENETICS; GENOTYPE; HEALTH CARE POLICY; INFANT; ISOLATION AND PURIFICATION; MALARIA FALCIPARUM; MIDDLE AGED; MISSENSE MUTATION; NEWBORN; PARASITOLOGY; PRESCHOOL CHILD; PREVALENCE;

PLASMODIUM FALCIPARUM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; CROSS-SECTIONAL STUDIES; DNA, PROTOZOAN; DRUG RESISTANCE; FEMALE; GENOTYPE; HEALTH POLICY; HUMANS; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MUTATION, MISSENSE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREVALENCE; PROTOZOAN PROTEINS; YEMEN; YOUNG ADULT;

EID: 79957475439     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-4-94     Document Type: Article

References (42)

1. The economic and social burden of malaria. J Sachs P Malaney, Nature 2002 415 680 685 10.1038/415680a 11832956 (Pubitemid 34136401)
2. Adhesion specificities of Plasmodium falciparum-infected erythrocytes involved in the pathogenesis of pregnancy-associated malaria. L Hviid, Am J Pathol 2007 170 1817 1819 10.2353/ajpath.2007.070246 17525250 (Pubitemid 47339256)
3. Discovery: an interactive resource for the rational selection and comparison of putative drug target proteins in malaria. F Joubert CM Harrison RJ Koegelenberg CJ Odendaal TA de Beer, Malar J 2009 8 178 10.1186/1475-2875-8-178 19642978
4. Prevention and control of malaria and sleeping sickness in Africa: Where are we and where are we going? V Corbel MC Henry, Parasit Vectors 2011 4 37 10.1186/1756-3305-4-37 21410946
5. Therapeutic efficacy of chloroquine for treatment of Plasmodium vivax malaria cases in Halaba district, South Ethiopia. T Ketema K Getahun K Bacha, Parasit Vectors 2011 4 46 10.1186/1756-3305-4-46 21453465
6. Drug resistance in Malaria. B Bloland, Geneva: World Health Organization 2001 27 WHO/CDS/DRS/2001-4
7. A molecular marker for chloroquine-resistant falciparum malaria. A Djimde OK Doumbo JF Cortese K Kayentao S Doumbo Y Diourte A Dicko XZ Su T Nomura DA Fidock, et al. N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152 (Pubitemid 32108530)
8. Combating malaria in Africa. JF Trape G Pison A Spiegel C Enel C Rogier, Trends Parasitol 2002 18 224 230 10.1016/S1471-4922(02)02249-3 11983604 (Pubitemid 34442597)
9. Spread and evolution of Plasmodium falciparum drug resistance. T Mita K Tanabe K Kita, Parasitol Int 2009 58 201 209 10.1016/j.parint.2009.04.004 19393762
10. World Malaria Report. WHO, Book World Malaria Report City: World Health Organization 2009
11. Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau. J Ursing PE Kofoed A Rodrigues L Rombo JP Gil, Am J Trop Med Hyg 2007 76 844 848 17488902 (Pubitemid 351627666)
12. Molecular diagnosis of resistance to antimalarial drugs during epidemics and in war zones. AA Djimde A Dolo A Ouattara S Diakite CV Plowe OK Doumbo, J Infect Dis 2004 190 853 855 10.1086/422758 15272415 (Pubitemid 39050017)
13. Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. A Djimde OK Doumbo RW Steketee CV Plowe, Lancet 2001 358 890 891 10.1016/S0140-6736(01)06040-8 11567708 (Pubitemid 32900575)
14. A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance. V Lakshmanan PG Bray D Verdier-Pinard DJ Johnson P Horrocks RA Muhle GE Alakpa RH Hughes SA Ward DJ Krogstad, et al. EMBO J 2005 24 2294 2305 10.1038/sj.emboj.7600681 15944738 (Pubitemid 41032582)
15. Prevalence of pfcrt mutations in Congolese and Malawian Plasmodium falciparum isolates as determined by a new Taqman assay. PE Wilson W Kazadi DD Kamwendo V Mwapasa A Purfield SR Meshnick, Acta Trop 2005 93 97 106 10.1016/j.actatropica.2004.09.010 15589802 (Pubitemid 39611359)
16. High frequency of Plasmodium falciparum PfCRT K76T and PfpghN86Y in patients clearing infection after chloroquine treatment in the Sudan. N Tagelsir Z Ibrahim A Medani O Salih A Hamad H Giha A El-Agib B Khan N Saeed M Ibrahim, Acta Trop 2006 97 19 25 10.1016/j.actatropica.2005.07.030 16171768 (Pubitemid 41758512)
17. Prevalence of the K76T mutation in the pfcrt gene of Plasmodium falciparum among chloroquine responders in India. S Vinayak S Biswas V Dev A Kumar MA Ansari YD Sharma, Acta Trop 2003 87 287 293 10.1016/S0001-706X(03) 00021-4 12826304 (Pubitemid 36776315)
18. Role of pfmdr1 mutations on chloroquine resistance in Plasmodium falciparum isolates with pfcrt K76T from Papua New Guinea. T Mita A Kaneko F Hombhanje I Hwaihwanje N Takahashi H Osawa T Tsukahara A Masta JK Lum T Kobayakawa, et al. Acta Trop 2006 98 137 144 10.1016/j.actatropica.2006.03.002 16620743 (Pubitemid 43783140)
19. The PfCRT (K76T) point mutation in Plasmodium falciparum, and its usefulness for monitoring chloroquine resistance. MR Ranjit A Das GP Chhotray RN Roth SK Kar, Ann Trop Med Parasitol 2004 98 879 882 10.1179/000349804X3162 15667720 (Pubitemid 40013194)
20. Widespread occurrence of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) gene haplotype SVMNT in P. falciparum malaria in India. PG Vathsala A Pramanik S Dhanasekaran CU Devi CR Pillai SK Subbarao SK Ghosh SN Tiwari TS Sathyanarayan PR Deshpande, et al. Am J Trop Med Hyg 2004 70 256 259 15031513 (Pubitemid 38366528)
21. High frequency of PfCRT 76T in two Malian villages and its prevalence in severe relative to non-severe malaria. M Wele AA Djimde A Guindo AH Beavogui IZ Traore A Sadou D Blaise DA Diallo TE Wellems OK Doumbo, Acta Trop 2011
22. Prevalence of Plasmodium falciparum pfcrt polymorphisms and in vitro chloroquine sensitivity in Senegal. JP Daily C Roberts SM Thomas O Ndir T Dieng S Mboup DF Wirth, Parasitology 2003 126 401 405 10.1017/S0031182003002981 12793643 (Pubitemid 36649294)
23. Short report: association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan. EO Ochong Broek van den IV K Keus A Nzila, Am J Trop Med Hyg 2003 69 184 187 13677373
24. Chloroquine-resistant Plasmodium falciparum local strain in Taiz Governorate, Republic of Yemen. HO Alkadi MT Al-Maktari MA Nooman, Chemotherapy 2006 52 166 170 10.1159/000093592 16720983 (Pubitemid 43882413)
25. Malaria status in Al-Hodeidah Governorate, Republic of Yemen. Part II: Human factors causing the persistence of chloroquine resistant P. falciparum local strain. MT Al-Maktari HK Bassiouny, J Egypt Soc Parasitol 2003 33 829 839 14708856
26. Malaria in late pregnancy in Al Hodeidah Governorate, Yemen. HK Bassiouny MT Al-Maktari, East Mediterr Health J 2005 11 606 617 16700375
27. Severe malaria in children in Yemen: two site observational study. A Al-Taiar S Jaffar A Assabri M Al-Habori A Azazy N Al-Mahdi K Ameen BM Greenwood CJ Whitty, BMJ 2006 333 827 10.1136/bmj.38959.368819.BE 17053235
28. Molecular epidemiology of Plasmodium species prevalent in Yemen based on 18 s rRNA. AM Al-Mekhlafi MA Mahdy AA A MY Fong, Parasit Vectors 3 110
29. Clinical situation of endemic malaria in Yemen. A Al-Mekhlafi M Mahdy A Azazy M Fong, Tropical Biomedicine 2010 27 551 558 21399597
30. The prevalence and degree of resistance of Plasmodium falciparum to first-line antimalarial drugs: an in vitro study from a malaria endemic region in Yemen. H Al-Shamahy AH Al-Harazy NS Harmal AM Al-Kabsi, Ann Saudi Med 2007 27 432 436 10.4103/0256-4947.51457 18059124 (Pubitemid 351234119)
31. Malaria Report. NMCP, Book Malaria Report City: National Malaria Control Programme 2002
32. Malaria signs and infection rate among asymptomatic schoolchildren in Hajr Valley, Yemen. MA Bin Mohanna AS Bin Ghouth YA Rajaa, East Mediterr Health J 2007 13 35 40 17546903
33. Molecular epidemiology of Plasmodium species prevalent in Yemen based on 18s rRNA. AM Al-Mekhlafi MA Mahdy AA Azazy MY Fong, Parasit Vectors 2010 3 110 10.1186/1756-3305-3-110 21092097
34. Relationship between the Pfcrt T76 and the Pfmdr-1 Y86 mutations in Plasmodium falciparum and in vitro/in vivo chloroquine resistance in Burkina Faso, West Africa. H Tinto JB Ouedraogo A Erhart C Van Overmeir JC Dujardin E Van Marck TR Guiguemde U D'Alessandro, Infect Genet Evol 2003 3 287 292 10.1016/j.meegid.2003.08.002 14636690 (Pubitemid 37408279)
35. Malaria and intestinal parasitosis among children presenting to the paediatric centre in Sana'a, Yemen. AA Azazy YA Raja'a, East Mediterr Health J 2003 9 1048 1053 16450536 (Pubitemid 40521247)
36. Drug resistance-virulence relationship in Plasmodium falciparum causing severe malaria in an area of seasonal and unstable transmission. HA Giha MI Elbashir AE IE AE TM GE ElGhazali MJ Mackinnon HA Babiker, Acta Trop 2006 97 181 187 10.1016/j.actatropica.2005.10.004 16336938 (Pubitemid 43087752)
37. No variation in the prevalence of point mutations in the Pfcrt and Pfmdr1 genes in isolates from Gabonese patients with uncomplicated or severe Plasmodium falciparum malaria. PI Mayengue Y Kalmbach S Issifou PG Kremsner F Ntoumi, Parasitol Res 2007 100 487 493 17096149 (Pubitemid 46011259)
38. The PfCRT (K76T) point mutation favours clone multiplicity and disease severity in Plasmodium falciparum infection. MR Ranjit A Das GP Chhotray BP Das BN Das AS Acharya, Trop Med Int Health 2004 9 857 861 10.1111/j.1365-3156.2004. 01286.x 15303989 (Pubitemid 39120142)
39. Rethinking the economic costs of malaria at the household level: evidence from applying a new analytical framework in rural Kenya. JM Chuma M Thiede CS Molyneux, Malar J 2006 5 76 10.1186/1475-2875-5-76 16939658
40. Malaria risk factors in Amerindian children in French Guiana. S Hustache M Nacher F Djossou B Carme, Am J Trop Med Hyg 2007 76 619 625 17426159 (Pubitemid 351627696)
41. Socioeconomic and environmental factors important for acquiring non-severe malaria in children in Yemen: a case-control study. A Al-Taiar A Assabri M Al-Habori A Azazy A Algabri M Alganadi CJ Whitty S Jaffar, Trans R Soc Trop Med Hyg 2009 103 72 78 10.1016/j.trstmh.2008.09.010 18950826
42. Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum field isolates from Myanmar. JM Kang SU Moon JY Kim SH Cho K Lin WM Sohn TS Kim BK Na, Malar J 2010 9 131 10.1186/1475-2875-9-131 20478015